Rankings
▼
Calendar
RCKT FY 2020 Earnings — Rocket Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
RCKT
Rocket Pharmaceuticals, Inc.
$572M
FY 2020 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$1M
Operating Income
-$136M
Net Income
-$147M
EPS (Diluted)
$-2.52
Cash Flow
Operating Cash Flow
-$75M
Free Cash Flow
-$104M
Stock-Based Comp.
$19M
Balance Sheet
Total Assets
$591M
Total Liabilities
$87M
Stockholders' Equity
$504M
Cash & Equivalents
$297M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
-$1M
-$426,000
-168.8%
Operating Income
-$136M
-$76M
-78.6%
Net Income
-$147M
-$83M
-76.2%
← Q4 2019
All Quarters
Q1 2020 →